| Latest | F'cast | |
|---|---|---|
| Div Yield | 2.5% | 2.9% |
| Div Cover | 2.2 | 2.2 |
| Op Mrgn | 22.7% | 23.2% |
| ROCE | 61.1% |
| Latest | F'cast | |
|---|---|---|
| P/E | 17.8 | 16.5 |
| PEG | 0.6 | 2.1 |
| Pr/Revenue | 2.9 | 2.7 |
| Pr/Book | 11.5 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 6.6% | 5.9% |
| PBT | 25.9% | 8.4% |
| EPS | 28.4% | 7.7% |
| DPS | 57.1% | 9.4% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-07 | 804.80 | 55.20 | 29.70p | 19.6 | 2.8 | +7% | 15.75p | 2.7% |
| 31-Dec-08 | 911.10 | 96.30 | 48.00p | 10.8 | 0.2 | +62% | 19.75p | 3.8% |
| 31-Dec-09 | 827.50 | 90.80 | 53.80p | 14.9 | 1.2 | +12% | 21.50p | 2.7% |
| 31-Dec-10 | 1,001.90 | 192.30 | 95.40p | 16.9 | 0.2 | +77% | 35.00p | 2.2% |
| 31-Dec-11 | 1,068.40 | 242.20 | 122.50p | 14.7 | 0.5 | +28% | 55.00p | 3.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 1,131.96 | 262.55 | 131.99p | 16.5 | 2.1 | +8% | 60.20p | 2.9% |
| 31-Dec-13 | 1,205.51 | 288.17 | 144.65p | 15.1 | 1.6 | +10% | 66.41p | 3.2% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| Director/PDMR Shareholding | 11-May-2012 | 16:26 | RNS |
| Director/PDMR Shareholding | 01-May-2012 | 13:45 | RNS |
| Result of AGM | 26-Apr-2012 | 15:17 | RNS |
| Thursday broker round-up | 10-May-2012 | ShareCast |
| Friday tips round-up: Croda, Whitbread, Go-Ahead | 27-Apr-2012 | ShareCast |
| FTSE 100 movers: Whitbread rises as AstraZeneca ... | 26-Apr-2012 | ShareCast |
| Second Croda deal for Aquapharm | 13-Jul-2011 | The Scotsman |
| No consumer slump for Croda | 29-Apr-2011 | The Independent |
| CRODA FIZZES AFTER SOLVAY DEAL | 05-Apr-2011 | Express & Star |
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 11-May-12 | Transfer From | Keith Layden | 0.000p | 6 | £0.00 |
| 11-May-12 | Transfer From | Sean Christie | 0.000p | 5 | £0.00 |
| 11-May-12 | Transfer From | Steve Foots | 0.000p | 6 | £0.00 |
| Currency | UK Pounds |
| Share Price | 2,180.00p |
| Change Today | -1.00p |
| % Change | -0.05 % |
| 52 Week High | 2,282.00p |
| 52 Week Low | 1,597.00p |
| Volume | 507,086 |
| Shares Issued | 139.95m |
| Market Cap | £3,050.91m |
| Beta | 1.00 |
| RiskGrade | 135 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 6 |
| Buy | 0 |
| Neutral | 6 |
| Sell | 1 |
| Strong Sell | 3 |
| Total | 16 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 02-May-12 | 31-Aug-11 |
| Paid | 01-Jun-12 | 07-Oct-11 |
| Amount | 30.25p | 24.75p |
| Time | Volume / Share Price |
| 16:47 | 8,006 @ 2,161.22p |
| 16:47 | 3,597 @ 2,161.22p |
| 16:46 | 7,393 @ 2,172.18p |
| 16:46 | 3,322 @ 2,172.18p |
| 16:45 | 4,150 @ 2,178.59p |
| CEO | Michael Humphrey |
| Finance Director | Sean Christie |
| Chair | Martin Flower |
You are here: research